Literature DB >> 20513803

Stem cell transplantation for paroxysmal nocturnal hemoglobinuria.

Robert A Brodsky.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20513803      PMCID： PMC2878778          DOI： 10.3324/haematol.2010.023176

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  20 in total

1.  Conditioning with high-dose cyclophosphamide may not be sufficient to provide a long-term remission of paroxysmal nocturnal hemoglobinuria following syngeneic peripheral blood stem cell transplantation.

Authors:  S G Cho; J Lim; Y Kim; H S Eom; C Y Jin; C W Han; C C Kim
Journal:  Bone Marrow Transplant       Date:  2001-11       Impact factor: 5.483

2.  The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria.

Authors:  Peter Hillmen; Neal S Young; Jörg Schubert; Robert A Brodsky; Gerard Socié; Petra Muus; Alexander Röth; Jeffrey Szer; Modupe O Elebute; Ryotaro Nakamura; Paul Browne; Antonio M Risitano; Anita Hill; Hubert Schrezenmeier; Chieh-Lin Fu; Jaroslaw Maciejewski; Scott A Rollins; Christopher F Mojcik; Russell P Rother; Lucio Luzzatto
Journal:  N Engl J Med       Date:  2006-09-21       Impact factor: 91.245

3.  Successful application of nonmyeloablative transplantation for paroxysmal nocturnal hemoglobinuria.

Authors:  K Suenaga; Y Kanda; H Niiya; K Nakai; T Saito; A Saito; M Ohnishi; T Takeuchi; R Tanosaki; A Makimoto; S Miyawaki; T Ohnishi; S Kanai; K Tobinai; Y Takaue; S Mineishi
Journal:  Exp Hematol       Date:  2001-05       Impact factor: 3.084

4.  The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9.

Authors:  S A Rollins; P J Sims
Journal:  J Immunol       Date:  1990-05-01       Impact factor: 5.422

5.  Multilineage glycosylphosphatidylinositol anchor-deficient haematopoiesis in untreated aplastic anaemia.

Authors:  G L Mukhina; J T Buckley; J P Barber; R J Jones; R A Brodsky
Journal:  Br J Haematol       Date:  2001-11       Impact factor: 6.998

6.  Clinical course and flow cytometric analysis of paroxysmal nocturnal hemoglobinuria in the United States and Japan.

Authors:  Jun-Ichi Nishimura; Yuzuru Kanakura; Russell E Ware; Tsutomu Shichishima; Hideki Nakakuma; Haruhiko Ninomiya; Carlos M Decastro; Sharon Hall; Akihisa Kanamaru; Keith M Sullivan; Hideaki Mizoguchi; Mitsuhiro Omine; Taroh Kinoshita; Wendell F Rosse
Journal:  Medicine (Baltimore)       Date:  2004-05       Impact factor: 1.889

7.  Natural history of paroxysmal nocturnal haemoglobinuria using modern diagnostic assays.

Authors:  Victor M Moyo; Galina L Mukhina; Elizabeth S Garrett; Robert A Brodsky
Journal:  Br J Haematol       Date:  2004-07       Impact factor: 6.998

8.  Bone marrow transplantation for paroxysmal nocturnal hemoglobinuria: eradication of the PNH clone and documentation of complete lymphohematopoietic engraftment.

Authors:  J H Antin; D Ginsburg; B R Smith; D G Nathan; S H Orkin; J M Rappeport
Journal:  Blood       Date:  1985-12       Impact factor: 22.113

9.  Natural history of paroxysmal nocturnal hemoglobinuria.

Authors:  P Hillmen; S M Lewis; M Bessler; L Luzzatto; J V Dacie
Journal:  N Engl J Med       Date:  1995-11-09       Impact factor: 91.245

10.  Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes.

Authors:  M E Medof; T Kinoshita; V Nussenzweig
Journal:  J Exp Med       Date:  1984-11-01       Impact factor: 14.307
View more
  14 in total

1.  Hematopoietic Cell Transplantation for Paroxysmal Nocturnal Hemoglobinuria in the Age of Eculizumab.

Authors:  Jason P Cooper; Rafic J Farah; Philip A Stevenson; Ted A Gooley; Rainer Storb; Bart L Scott
Journal:  Biol Blood Marrow Transplant       Date:  2019-02-01       Impact factor: 5.742

2.  Natural history of paroxysmal nocturnal hemoglobinuria clones in patients presenting as aplastic anemia.

Authors:  Jeffrey J Pu; Galina Mukhina; Hao Wang; William J Savage; Robert A Brodsky
Journal:  Eur J Haematol       Date:  2011-07       Impact factor: 2.997

3.  Strategy for bone marrow transplantation in eculizumab-treated paroxysmal nocturnal hemoglobinuria.

Authors:  Kyoko Taniguchi; Masaya Okada; Satoshi Yoshihara; Akihiro Sawada; Tazuko Tokugawa; Shinichi Ishii; Katsuji Kaida; Kazuhiro Ikegame; Kentaro Minagawa; Toshimitsu Matsui; Hiroyasu Ogawa
Journal:  Int J Hematol       Date:  2011-09-17       Impact factor: 2.490

Review 4.  Paroxysmal nocturnal hemoglobinuria.

Authors:  Robert A Brodsky
Journal:  Blood       Date:  2014-09-18       Impact factor: 22.113

Review 5.  Paroxysmal Nocturnal Hemoglobinuria: From Bench to Bed.

Authors:  Amrallah A Mohammed; Hani El-Tanni; Tariq Al-Malki Atiah; Arwa Al-Malki Atiah; Marwan Al-Malki Atiah; Ayman A Rasmy
Journal:  Indian J Hematol Blood Transfus       Date:  2016-02-12       Impact factor: 0.900

6.  Haploidentical vs matched sibling donor transplant for paroxysmal nocturnal haemoglobinuria: A multicenter study.

Authors:  Limin Liu; Shunqing Wang; Erlie Jiang; Yanming Zhang; Jianyong Li; Yuewen Fu; Meiqing Lei; Kailin Xu; Mingzhen Yang; Yinghao Lu; Miao Miao; Depei Wu
Journal:  Blood Cancer J       Date:  2022-06-24       Impact factor: 9.812

Review 7.  Paroxysmal nocturnal haemoglobinuria.

Authors:  Anita Hill; Amy E DeZern; Taroh Kinoshita; Robert A Brodsky
Journal:  Nat Rev Dis Primers       Date:  2017-05-18       Impact factor: 52.329

8.  A Rare and Misdiagnosed Entity Paroxysmal Nocturnal Hemoglobinuria: A Case Report.

Authors:  Biraj Pokhrel; Sandesh Gautam; Shambhu Khanal; Nishan B Pokhrel; Anjan Shrestha
Journal:  Cureus       Date:  2021-05-08

9.  Response of paroxysmal nocturnal hemoglobinuria clone with aplastic anemia to rituximab.

Authors:  Radha Raghupathy; Olga Derman
Journal:  Case Rep Hematol       Date:  2012-05-07

10.  Long Standing Eculizumab Treatment without Anticoagulant Therapy in High-Risk Thrombogenic Paroxysmal Nocturnal Hemoglobinuria.

Authors:  Hassan A Al-Jafar; Salma M AlDallal; Haifa A Askar; Ali M Aljeraiwi; Ahmad Al-Alansari
Journal:  Hematol Rep       Date:  2015-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.